FibroGen Announces 1-for-25 Reverse Stock Split
SAN FRANCISCO, June 12, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that it will implement…
11,180$
0,81%
Echtzeit-Aktienkurs FibroGen Inc
Bid:
Ask:
Nachrichten zur FibroGen Inc Aktie
FibroGen, Inc. (FGEN) Q1 2025 Earnings Call Transcript
…
FibroGen, Inc. (FGEN) Q4 2024 Earnings Call Transcript
…
FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results
SAN FRANCISCO, March 17, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today reported financial results for the…
FibroGen, Inc. (FGEN) Q2 2024 Earnings Call Transcript
…
FibroGen to Host Part II of Virtual KOL Investor Event Series to Review FG-3246 Development Program in Metastatic Castration-Resistant Prostate Cancer on June 26, 2024
SAN FRANCISCO, June 18, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced it will host the…
FibroGen, Inc. (FGEN) Q1 2024 Earnings Call Transcript
…
FibroGen to Report First Quarter 2024 Financial Results
SAN FRANCISCO, April 29, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce first quarter 2024 financial…
FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer
SAN FRANCISCO, April 02, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced topline data from the Fortis…
FibroGen, Inc. 2023 Q4 - Results - Earnings Call Presentation
…
FibroGen, Inc. (FGEN) Q4 2023 Earnings Call Transcript
…